ArticleMultiple sclerosis journal - experimental, translational and clinical

Ocrelizumab after natalizumab in JC-virus positive relapsing remitting multiple sclerosis patients.

Zygj van Lierop et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.